DRG will participate at MEDICA 2021 (Booth 3/A69)
DRG is proud to be a featured participant at MEDICA 2021, held in Düsseldorf from November 15 - 18.
We will showcase an expansive collection of its most cutting-edge products to the medical diagnostic community gathered at MEDICA.
We will offer live demonstrations of our fully automated, continuous access analyzer DRG:HYBRID-XL®.
This year we would like to introduce you to the newly developed and UNIQUE tests for the DRG:HYBRiD-XL® for monitoring antibiotic therapies: Ceftazidime - Ciprofloxacin - Linezolid.
Furthermore, we recently developed assays to determine AMH (Anti-Mullerian Hormone) and Pancreatic Elastase (stool), which can nicely be bundled with Calprotectin (stool).
Additionally, we will present several new DRG ELISAs: UNIQUE Antibiotic TDMs in ELISA format Ceftazidime, Ciprofloxacin and Linezolid, followed soon by Piperacillin, Cefepim and Amoxicillin.
During pandemic our R&D team was very hardworking and developed three ELISAs for the detection of antibodies to SARS-CoV-2:
1. SARS-CoV-2 (RBD) IgG (quantitative detection in IU/mL)
2. SARS-CoV-2 (RBD) Total Ab
3. SARS-CoV-2 IgG (quantification in antibody titer).
Moreover, we will display our new ELISA kits: UNIQUE Estriol total ELISA, AMH (Anti-Mullerian Hormone) ELISA, Salivary Estradiol HS ELISA and UNIQUE Salivary Hepcidin ELISA.
We are looking forward to meeting you there!
